ARENTFOX SCHIFF LLP for CSL BEHRING
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax Reform legislation, including Border Adjustment Tax and state and local tax deduction
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. tax policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
| SONJA NESBIT | — |
Health Issues HCR
Orphan drug tax exclusion in the Patient Protection and Affordable Care Act Legislation pertaining to orphan drugs H.R. 3163 (Medicare Part B Home Infusion Services Temporary Transitional Payment Act), all provisions
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. health care policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
| NORMAN FREDERICK LENT | — |
| SONJA NESBIT | — |
Trade (domestic/foreign) TRD
Renewal of the Office of Foreign Assets Control license for toll manufacturing of therapies for international distribution
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. trade policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.